Article Information
History
- March 16, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kevin Peikert, MD1,2,
- Hannes Glaß, PhD1,2,
- Enrica Federti3,
- Alessandro Matte3,
- Lisann Pelzl, PhD4,5,
- Katja Akgün, MD1,
- Tjalf Ziemssen, MD1,
- Rainer Ordemann, MD6,
- Florian Lang, MD4,
- The Network for translational research for Neuroacanthocytosis Patients,
- Lucia De Franceschi, MD3,‡ and
- Andreas Hermann, MD, PhD1,2,7,8,9,‡,*
- 1Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
- 2Translational Neurodegeneration Section „Albrecht Kossel“, Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, Germany
- 3Department of Medicine, University of Verona, Verona, Italy
- 4Department of Physiology I, University of Tübingen, Tübingen, Germany
- 5Transfusion Medicine, Medical Faculty, Eberhard Karl University, Tübingen, Germany
- 6Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
- 7Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany
- 8DZNE, German Center for Neurodegenerative Diseases, Research Sites Dresden and Rostock/Greifswald, Germany
- 9Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, Rostock, Germany
- ↵*Corresponding Author: Prof. Andreas Hermann, MD, PhD; Translational Neurodegeneration Section “Albrecht Kossel”; Department of Neurology; University Medical Center Rostock; Gehlsheimer Straße 20, 18147 Rostock, Germany; Phone: +49(0)381 494-9511; e-Mail: Andreas.Hermann{at}med.uni-rostock.de
↵‡ contributed equally to this work